Ovoca Bio reported EUR6.32M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 6M 1000K Jun/2026
ALKERMES USD 7.43B 629M Nov/2026
Avita Medical AUD 127.11M 21.64M Jun/2026
Dianthus Therapeutics USD 2.46B 2.87B Nov/2026
Great Western Mining Corporation EUR 2.58M 666.82K Dec/2025
Ionis Pharmaceuticals USD 4.52B 2.9B Nov/2026
IQVIA Holdings USD 48.06B 3.81B Nov/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Moderna USD 99.14B 22.26B Nov/2026
Organon & Co USD 3.55B 49.18M Nov/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Revvity USD 19.52B 2.61B Nov/2026
Tectonic Therapeutic USD 649M 69M Jun/2026
Viatris USD 22.53B 2.18B Nov/2026
Xeris Pharmaceuticals USD 1.44B 70M Nov/2026